Estimated cost efficacy of US Food and Drug Administration-approved treatments for acne

被引：6
|
作者：
Tassavor, Michael [1 ]
Payette, Michael J. [1 ]
机构：
[1] Univ Connecticut, Hlth Ctr, Dept Dermatol, Farmington, CT USA
来源：
DERMATOLOGIC THERAPY | 2019年 / 32卷 / 01期
关键词：
ISOTRETINOIN; BURDEN;
D O I：
10.1111/dth.12765
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea
    Darren M. Brenner
    Gregory S. Sayuk
    Advances in Therapy, 2020, 37 : 83 - 96
  • [22] Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the US Food and Drug Administration-Approved Duration
    McNicholas, Colleen
    Maddipati, Ragini
    Zhao, Qiuhong
    Swor, Erin
    Peipert, Jeffrey F.
    OBSTETRICS AND GYNECOLOGY, 2015, 125 (03): : 599 - 604
  • [23] Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor Immunity
    Sukhatme, Vidula V.
    Ramalingam, Suresh S.
    Ahmed, Rafi
    Sukhatme, Vikas P.
    CANCER JOURNAL, 2019, 25 (02): : 88 - 99
  • [24] Readability of medication guides for Food and Drug Administration-approved biologics in dermatology
    Lau, Charles B.
    Smith, Gideon P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (04) : 388 - 389
  • [25] Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration-approved solid tumor therapies, 1995-2021
    Alabaku, Orges
    Laffey, Taylor N.
    Suh, Kangho
    Li, Meng
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (11): : 1219 - 1223
  • [26] Food and Drug Administration-Approved Treatments for Acute Bipolar Depression What We Have and What We Need
    Citrome, Leslie
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (04) : 334 - 338
  • [27] Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
    Alhamadani, Feryal
    Zhang, Kristy
    Parikh, Rajvi
    Wu, Hangyu
    Rasmussen, Theodore P.
    Bahal, Raman
    Zhong, Xiao-Bo
    Manautou, Jose E.
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (06) : 879 - 887
  • [28] Drug screening of food and drug administration-approved compounds against Babesia bovis in vitro
    Li, Yongchang
    Liu, Mingming
    Rizk, Mohamed Abdo
    Moumouni, Paul Franck Adjou
    Lee, Seung-Hun
    Galon, Eloiza May
    Guo, Huanping
    Gao, Yang
    Li, Jixu
    Beshbishy, Amani Magdy
    Nugraha, Arifin Budiman
    Ji, Shengwei
    Tumwebaze, Maria Agnes
    Benedicto, Byamukama
    Yokoyama, Naoaki
    Igarashi, Ikuo
    Xuan, Xuenan
    EXPERIMENTAL PARASITOLOGY, 2020, 210
  • [29] Real-world evidence for US Food and Drug Administration-approved oncology products, 2015 to 2020.
    Arondekar, Bhakti
    Duh, Mei Sheng
    Bhak, Rachel
    DerSarkissian, Maral
    Huynh, Lynn
    Wang, Kelsey
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [30] Why Is There No Food and Drug Administration-Approved Medication for Major Depression With Psychotic Features?
    Rothschild, Anthony J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (04) : 359 - 361
12345